KRIT1 Antibodies

Santa Cruz Biotechnology offers a broad range of KRIT1 monoclonal antibodies for research focused on understanding KRIT1 protein functions. KRIT1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KRIT1, also known as CCM1, is a key protein involved in maintaining vascular integrity and regulating cell adhesion. Research has shown that KRIT1 plays a significant role in the development of cerebral cavernous malformations, which can lead to severe neurological complications. Understanding KRIT1 function is essential for elucidating the mechanisms underlying vascular diseases and developing potential therapeutic strategies. KRIT1 research continues to reveal new insights into vascular development and disease progression. Advanced research techniques utilizing KRIT1 monoclonal antibodies enable detailed investigation of cellular pathways and molecular interactions. Ongoing studies of KRIT1 contribute to our understanding of vascular biology and potential treatment approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of vascular health and disease mechanisms.